民生銀行(01988.HK):完成贖回境外優先股 總贖回價15.1億美元
格隆匯12月14日丨民生銀行(01988.HK)公佈,根據境外優先股的條款及條件第5(b)項(該行選擇贖回)及中國銀保監會對該行贖回境外優先股無異議的覆函,該行已於2021年12月14日贖回全部而非部分境外優先股。境外優先股的總贖回價為15.10億美元(即(i)境外優先股的清算優先總額14.39億美元及(ii)此次股息7123.05萬美元的總和)。於贖回日贖回及註銷境外優先股後,概無已發行境外優先股。據此,該行已向香港聯合交易所有限公司申請將境外優先股除牌。有關除牌將於2021年12月15日下午四時正(北京時間)後生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.